Please assess the completion status of the following clinical trial:

Trial Title: ImageReady(TM) MR Conditional Pacing System Clinical Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Subject must have the ImageReady System as their initial (de novo) pacing system implant~* Subject has a Class I or II indication for implantation of a single or dual chamber pacemaker according to the ACC/AHA/HRS, or ESC guidelines, as appropriate per geography~* Subject is able and willing to undergo an MRI scan without intravenous sedation~* Subject is willing and capable of providing informed consent (which can include the use of a legally authorized representative (LAR) for documentation of informed consent) and participating in all testing/ visits associated with this clinical study at an approved clinical study center and at the intervals defined by this protocol~* Subject is age 18 or above, or of legal age to give informed consent specific to state and national law~Exclusion Criteria:~* Subject has or has had any pacing or ICD system implants~* Subject has any MR Unsafe implants or devices with an unknown MR status, including MR Unsafe sternal wires, neurostimulators, biostimulator, metals or alloys, per labeling of each implant~* Subject has any MR Conditional implants or devices that impact the ability to conduct this protocol~* Subject needs or will need another MR scan within 14 weeks of system implant, other than that required by the SAMURAI Study~* Subject has a known or suspected sensitivity to dexamethasone acetate (DXA)~* Subject has a mechanical tricuspid heart valve~* Subject is enrolled in any other concurrent study, with the exception of local mandatory governmental registries and observational studies/registries\* that are not in conflict and do not affect the following:~  * Schedule of procedures for the SAMURAI Study (i.e. should not cause additional or missed visits);~ * SAMURAI Study outcome (i.e. involve medications that could affect pacing thresholds);~ * Conduct of the SAMURAI Study per GCP/ ISO 14155:2011/ local regulations~* Subjects with documented permanent or persistent AF where the physician intends to implant a dual chamber pulse generator (single chamber VVIR pulse generators are acceptable)~* Subject is currently on the active heart transplant list~* Subject has documented life expectancy of less than 12 months~* Women of childbearing potential who are or might be pregnant at the time of study enrollment or ImageReady MR Conditional Pacing System implant (method of assessment upon physician's discretion)~* Subjects currently requiring dialysis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- MRI Group (Type: EXPERIMENTAL): Those subjects randomized to the MRI Group will undergo a study-specific MRI scan 6-9 weeks post-implant.
- Control Group (Type: EXPERIMENTAL): Those subjects randomized to the Control Group will not undergo s study-specific MRI scan. All follow-up time requirements are the same for the two groups.

Based on this trial design, predict the completion outcome and termination type (if applicable).